Bexarotene - ≥99%, high purity , Retinoid X receptor agonist, CAS No.153559-49-0, Retinoid X receptor agonist

Item Number

B125743

• Synonyms: Bexarotene | 153559-49-0 | Targretin | Targrexin | Targretyn | LGD1069 | Targret | LGD 1069 | bexaroteno | bexarotenum | LGD-1069 | LG100069 | 166175-31-1 | DTXSID1040619 | LG 1069 | HSDB 7453 | 4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic acid | p-(1-(5,6,7
• Specifications & Purity: Moligand™, ≥99%
• Biochemical and Physiological Mechanisms: Bexarotene (tradenamed Targretin) is an oral antineoplastic agent indicated by the U.S. Food and Drug Administration (FDA) (in 2000) for cutaneous T cell lymphoma. Bexarotene (tradenamed Targretin) has been used off-label for lung cancer, breast cancer, a
• Storage Temp: Store at -20°C
• Shipped In: Ice chest + Ice pads
• Grade: Moligand™
• Action Type: AGONIST, ANTAGONIST
• Mechanism of action: Retinoid X receptor agonist
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

Bexarotene (Targretin) is a selective RXR agonist approved for the treatment of CTCL.
A selective agonist of retinoid X receptors